Meet us at the 9th Drug Discovery Strategic Summit
We are attending the 9th Drug Discovery Strategic Summit in Boston, May 9-10, 2022. Connect with us and let us know if you’d like to schedule a meeting beforehand.
Meet us at Bio-IT World Conference & Expo 2022
Join us at Bio-IT World Conference & Expo, May 3-5, 2022, the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Don’t hesitate to let us know if you’d like to schedule a meeting beforehand.
Colin Hill to Speak at The World Medical Innovation Forum 2022
This year, the World Medical Innovation Forum will explore the promise of new gene and cell therapies, the challenges to their development and investment and market dynamics. The forum features more than 200 CEOs, industry, investment, and government senior leaders from across the Gene and Cell Therapy (GCT) ecosystem. On Tuesday, May 3, Colin Hill, will […]
Meet us at AACR
The AACR Annual Meeting is the focal point of the cancer research community. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Meeting highlights the work of the best minds in cancer research from institutions all over the world. Joe F. Donahue, our Chief Business Officer […]
Colin Hill to Speak at The Longwood Healthcare Leaders Winter Webconference
On Thursday, January 6, Colin Hill, will be moderating a panel on Expediting Research for Treatments and Cures at the Longwood Healthcare Leaders winter webconference. He will be joined by Christopher Coburn, CIO, Mass General Brigham; Ray Deshaies, SVP, Research, Amgen; Raj Devraj, CEO, Rectify Pharma; Brian McVeigh, CEO, Code Biotherapeutics and Chen Schor, Chair, […]
Cross-Industry Collaboration of GNS Healthcare, Amgen and Alliance for Clinical Trials in Oncology to Leverage AI to Advance Understanding of Treatment Response in Metastatic Colorectal Cancer
Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer CAMBRIDGE, Mass.– September 6, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced a cross-industry partnership with Amgen and the Alliance for Clinical Trials in Oncology (Alliance) that will apply causal […]
Iya Khalil featured in Forbes article on women making AI more accessible
May 7, 2018 –Artificial intelligence is impacting every industry so it is no wonder that this year’s Milken Global Institute focused how new technologies are changing industries, including health care. Forbes recently profiled the event, focusing on the number of women who are making artifical intelligence more accessible and less scary. The article featured Iya Khalil, co-founder […]
Colin Hill featured in STAT News Article on Patient Data
March 29, 2018 – In early March, the Centers for Medicare and Medicaid Services (CMS) announced two initiatives, MyHealthEData and Blue Button 2.0, which aims to improve the control that patients have over their health data. In a recent STAT News article, GNS Chairman, CEO, and Co-Founder Colin Hill spoke with reporter Casey Ross on the value […]
GNS Board Member Dr. Adrian Weller appointed as Programme Director for Artificial Intelligence at The Alan Turing Institute
Today, The Alan Turing Institute announced the appointment of Dr. Adrian Weller as Programme Director for Artificial Intelligence. The Institute, named in honor of Alan Turing and based in London, aims to make great leaps in data science research in order to change the world for the better. His role will enable the Institute to […]
Neo.Life features Iya Khalil in 2018 Biotech Breakthroughs and Big Ideas
In this January article, Neo.Life profiles the biggest biotech breakthroughs and big ideas for 2018, including thoughts from Iya Khalil, GNS co-founder and chief commercial officer. Iya speaks to the proliferation of emerging -omic data and how advances in artificial intelligence, and specifically causal machine learning, can use this data to drive better health outcomes […]